We are live on ! Find out more
AS

Altshuler Shaham Portfolio holdings

AUM $8.04B
1-Year Est. Return 44.04%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
AUM
$2.5B
AUM Growth
-$1.57B
Cap. Flow
-$1.64B
Cap. Flow %
-65.42%
Top 10 Hldgs %
88.43%
Holding
634
New
187
Increased
68
Reduced
174
Closed
179

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$184M
2
BAC icon
Bank of America
BAC
+$179M
3
C icon
Citigroup
C
+$176M
4
ICL icon
ICL Group
ICL
+$151M
5
JPM icon
JPMorgan Chase
JPM
+$148M

Sector Composition

Rank Sector Weight
1 Financials 42.42%
2 Materials 18.48%
3 Technology 15.22%
4 Industrials 13.02%
5 Utilities 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOLD
326
DELISTED
Amicus Therapeutics
FOLD
$26.6K ﹤0.01%
2,181
-140
-6% -$1.58K
MRNA icon
327
Moderna
MRNA
$25.4B
$26.6K ﹤0.01%
148
-758
-84% -$124K
SILK
328
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$26.5K ﹤0.01%
502
-143
-22% -$6.96K
BMRN icon
329
BioMarin Pharmaceuticals
BMRN
$13.3B
$26.5K ﹤0.01%
256
-36
-12% -$3.38K
MMSI icon
330
Merit Medical Systems
MMSI
$5.4B
$26.4K ﹤0.01%
+374
New +$25K
IONS icon
331
Ionis Pharmaceuticals
IONS
$9.28B
$26.3K ﹤0.01%
695
-690
-50% -$29K
HALO icon
332
Halozyme
HALO
$11.4B
$26.2K ﹤0.01%
460
-1,068
-70% -$54.7K
CRVL icon
333
CorVel
CRVL
$3.25B
$26.2K ﹤0.01%
+540
New +$26.9K
PDCO
334
DELISTED
Patterson Companies, Inc.
PDCO
$26.1K ﹤0.01%
931
-95
-9% -$2.62K
HSIC icon
335
Henry Schein
HSIC
$10B
$26K ﹤0.01%
326
-43
-12% -$3.26K
CHE icon
336
Chemed
CHE
$7.02B
$26K ﹤0.01%
51
-5
-9% -$2.43K
AAPL icon
337
PUT
Apple
AAPL
$4.46T
$25.8K ﹤0.01%
+100
New +$14.3K
NRC icon
338
NRC Health Common Stock
NRC
$471M
$25.8K ﹤0.01%
691
-67
-9% -$2.59K
IDXX icon
339
Idexx Laboratories
IDXX
$44.7B
$25.7K ﹤0.01%
+63
New +$24.5K
TMCI icon
340
Treace Medical Concepts
TMCI
$293M
$25.2K ﹤0.01%
+1,097
New +$25.3K
BIIB icon
341
Biogen
BIIB
$31.1B
$25.2K ﹤0.01%
+91
New +$25.7K
RMD icon
342
ResMed
RMD
$32.9B
$25K ﹤0.01%
120
-140
-54% -$30.8K
ADUS icon
343
Addus HomeCare
ADUS
$2.2B
$24.9K ﹤0.01%
250
-41
-14% -$4.29K
HURN icon
344
Huron Consulting
HURN
$2.47B
$24.6K ﹤0.01%
339
-66
-16% -$4.85K
HIMS icon
345
Hims & Hers Health
HIMS
$6.71B
$24.3K ﹤0.01%
3,795
-302
-7% -$1.72K
FRXB.WS
346
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$23.4K ﹤0.01%
+69,997
New +$11.2K
AMN icon
347
AMN Healthcare
AMN
$1.34B
$23K ﹤0.01%
224
-33
-13% -$3.8K
CCRN
348
DELISTED
Cross Country Healthcare
CCRN
$21.8K ﹤0.01%
+821
New +$26.8K
CRAI icon
349
CRA International
CRAI
$1.07B
$21.3K ﹤0.01%
+174
New +$19.2K
AIT icon
350
Applied Industrial Technologies
AIT
$13.2B
$20.5K ﹤0.01%
163
-90
-36% -$11K

Similar funds

Altshuler Shaham's Q4 2022 Portfolio in Review

As of Q4 2022, Altshuler Shaham held 634 positions worth $2.5B, down 39% from $4.07B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Altshuler Shaham withdrew a net $1.64B in Q4 2022, closing 179 positions and reducing 174 holdings. Its most notable exit was Global X Copper Miners ETF NEW, an estimated $654M position sold in full.

By sector, the portfolio is most concentrated in Financials at 42% of assets, up from 8.8% a quarter earlier, followed by Materials and Technology.

Against the trend, Altshuler Shaham opened a new position in Kenon Holdings worth $120M.

  • Altshuler Shaham's largest Q4 2022 buy was Kenon Holdings: 3,615,360 shares worth $120M.
  • Altshuler Shaham added most to Wells Fargo in Q4 2022, an estimated $184M increase.
  • Altshuler Shaham's biggest Q4 2022 reduction was Deere & Co, cutting an estimated $399M.
  • Altshuler Shaham fully exited Global X Copper Miners ETF NEW in Q4 2022, selling an estimated $654M.
  • Altshuler Shaham's ten largest holdings make up 88% of its $2.5B portfolio in Q4 2022.
  • Altshuler Shaham opened 187 new positions and closed 179 in Q4 2022.
  • Altshuler Shaham's portfolio value fell 39% quarter-over-quarter to $2.5B.

Based on Altshuler Shaham's 13F filing for Q4 2022, filed 15 Feb 2023.